Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0035-1558131
Pregnancy Induced Autoimmune Warm Antibodies Hemolytic Anemia: A Case Report
Schwangerschaftsinduzierte autoimmunhämolytische Anämie vom Wärmetyp: ein FallberichtPublication History
received 21 April 2015
revised 21 August 2015
accepted 25 August 2015
Publication Date:
14 December 2015 (online)
![](https://www.thieme-connect.de/media/gebfra/201511/lookinside/thumbnails/10-1055-s-0035-1558131_gf973-1.jpg)
Abstract
Background: Autoimmune haemolytic anaemia (AIHA), caused primarily by pregnancy, is poorly described in the literature. There is especially little information on coping with cases that are not responsive to glucocorticoid treatment, monitoring a fetal condition, and identifying fetal haemolytic anaemia as early as possible. Case: A case of pregnancy-induced autoimmune haemolytic anaemia is reported with major problems in differential diagnosis, treatment and the risks posed to both the mother and the fetus. The anaemia went into spontaneous remission of the disease several weeks after delivery. Conclusion: Autoimmune haemolytic anaemia is rarely reported in literature, but can be dangerous for both fetus and mother. It therefore should be described and discussed among obstetricians and gynaecologists, and the etiopathogenesis should be further studied.
Zusammenfassung
Hintergrund: Es gibt nur wenige Berichte zur schwangerschaftsinduzierten autoimmunhämolytischen Anämie (AIHA). Noch weniger Informationen gibt es über die adäquate Vorgehensweise bei Patientinnen, die nicht auf eine Behandlung mit Glukokortikoiden ansprechen, sowie zur Bedeutung einer Überwachung des fetalen Zustands und einer frühestmöglichen Ermittlung einer fetalen hämolytischen Anämie. Fallbericht: Es wird hier der Fall einer Frau mit schwangerschaftsinduzierter autoimmunhämolytischer Anämie berichtet, bei der erhebliche Probleme bei der Stellung der Differenzialdiagnose auftraten. Es wird über die Behandlung und Risiken für Mutter und Kind berichtet. Einige Wochen nach der Entbindung trat eine Spontanremission der Anämie ein. Schlussfolgerung: In der Literatur gibt es nur wenige Berichte zur autoimmunhämolytischen Anämie, die aber ein erhebliches Risiko für Mutter und Fetus darstellt. Sie sollte daher eingehend beschrieben und unter Gynäkologen sowie Geburtshelfern diskutiert werden. Es sind weitere Studien zur Klärungen der Ätiopathogenese gefordert.
-
References
- 1 Baumann R, Rubin H. Autoimmune hemolytic anemiaduring pregnancy with hemolytic disease in the newborn. Blood 1973; 41: 293-297
- 2 Tsai YC, Chang JM, Chang JC et al. Idiopathic autoimmune hemolytic anemia during pregnancy. J Formos Med Assoc 1994; 93: 328-331
- 3 Benraad CE, Scheerder HA, Overbeeke MA. Autoimmune haemolytic anaemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1994; 55: 209-211
- 4 Ng SC, Wong KK, Raman S et al. Autoimmune haemolytic anaemia in pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol 1990; 37: 83-85
- 5 Pourrat O, Coudroy R, Pierre F. Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators. Eur J Obstet Gynecol Reprod Biol 2015; 189: 68-72
- 6 Gurpreet D, Cornett PA, Tierney L. Hemolytic anemia. Am Fam Physician 2004; 69: 2599-2607
- 7 Cunningham FG et al. Hematological Disorders. In: Cunningham FG, et al., eds. Williams Obstetrics. 23rd ed. New York: McGraw-Hill; 2010: 1079-1083
- 8 Kumar R, Advani AR, Sharan J et al. Pregnancy induced hemolytic anemia: an unexplained entity. Ann Hematol 2001; 80: 623-626
- 9 Katsuragi S, Sameshima H, Omine M et al. Pregnancy-induced hemolytic anemia with a possible immune-related mechanism. Obstet Gynecol 2008; 111: 528-529
- 10 Sharma P, Sthapit R. Unexplained hemolytic anemia of pregnancy: case report with review of related literature. Nepal Journal of Obstetrics and Gynaecology 2008; 3: 49-50
- 11 Craig GA, Turner RL. A case of symptomatic haemolytic anaemia in pregnancy. Br Med J 1955; 4920: 1003-1005
- 12 Dominico SA, Janmohamed M, Magesa A et al. Coombs negative hemolytic anemia of unknown origin in pregnancy. J Blood Lymph 2012; 2: 103
- 13 Sokol RJ, Hewitt S, Stamps BK. Erythrocyte autoantibodies, autoimmune haemolysis and pregnancy. Vox Sang 1982; 43: 169-176
- 14 Starksen NF, Bell WR, Kickler TS. Unexplained hemolytic anemia associated with pregnancy. Am J Obstet Gynecol 1983; 146: 617-622
- 15 Lawe JE. Successful exchange transfusion of an infant for AIHA developing late in motherʼs pregnancy. Transfusion 1982; 22: 66-68
- 16 Ensworth S. Anti-rheumatic medications during pregnancy and lactation. J Rheumatol 2002; 2: 1-16
- 17 Hoffbrand AV, Moss PAH, Pettit JE. Essential Haematology. 5th ed. New York: Wiley-Blackwell; 2006: 58-72
- 18 Klink DT, van Elburg RM, Schreurs MW et al. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol 2008; 2008: 271363
- 19 Friedrichs B, Tiemann M, Salwender H et al. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006; 91: 1426-1427
- 20 Barcellini W. Haemostasis and immunity: cross-talking systems?. Blood Transfuse 2014; 12: 348-349
- 21 Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica 2014; 99: 1547-1554
- 22 Chaplin HJ, Cohen R, Bloomberg G et al. Pregnancy and idiopathic autoimmune haemolytic anaemia: a prospective study during 6 months gestation and 3 months post-partum. Br J Haematol 1973; 24: 219-229
- 23 Issaragrisil S, Kruatrachue M. An association of pregnancy and autoimmune haemolytic anaemia. Scand J Haematol 1983; 31: 63-68
- 24 Pretlove SJ, Fox CE, Khan KS et al. Noninvasive methods of detecting fetal anaemia: a systematic review and meta-analysis. BJOG 2009; 116: 1558-1567
- 25 Rosse W, Schrier SL. Clinical features and diagnosis of autoimmune hemolytic anemia: Warm agglutinins. UpToDate 2013;
- 26 Darlene A, Calhoun DO. Postnatal diagnosis and management of alloimmune hemolytic disease in newborn. UpToDate 2015;